FDA Proposed Ephedra Guidelines
From the friendly folks at the CSOM |
The FDA invites written comments on the proposal until august 18, 1997. It would be good for acupuncturists and acupuncture associations, to write the FDA and request that any restrictions on ephedra or Ma Huang take into consideration the fact that licensed acupuncturists use ephedra fortreating their patients and that allowances be made for this. All comments received will be reviewed and considered before developing the final rule.
You can write the FDA at
Dockets Management Branch,
HFA-305, Food and Drug Administration,
12410 Parklawn Dr.
Room 1-23
Rockville, MD 20857
Acupuncture.com |